Schedule A Demo
🚨 Meet GEMMS, Inc at ACC.26 | March 28–30, 2026 | Ernest N. Morial Convention Center | New Orleans, LA | Featured Exhibitor Booth #2756
Schedule a Conversation

1. Cross-Disciplinary Care Coordination

  • GEMMS ONE facilitates collaboration between cardiologists and oncologists by integrating comprehensive patient records, including both cardiovascular and oncological data. This integration ensures that both the cardiologist and oncologist have access to the patient's full health history, cancer treatment regimens, and cardiovascular risk factors​​. 
  • GEMMS ONE supports the creation of coordinated care plans that involve both cardiology and oncology teams. This helps manage the complex interplay between cancer treatments and heart health, ensuring that cardiovascular risks are monitored throughout the course of cancer treatment​.

2. Cardiotoxicity Monitoring

  • GEMMS ONE helps cardio-oncologists track cardiotoxicity—the adverse effects of cancer therapies on the heart. The system allows clinicians to monitor the impact of treatments such as chemotherapy (e.g., anthracyclines), radiation, and targeted therapies on heart function​​. 
  • GEMMS ONE provides risk calculators and decision support tools that help predict the likelihood of cardiotoxic effects based on a patient's cancer treatment plan, medical history, and other risk factors. This enables cardio-oncologists to make informed decisions about adjusting cancer treatments to minimize heart damage​​. 

3. Patient Monitoring and Remote Care

  • GEMMS ONE supports continuous monitoring of cardiovascular function in cancer patients, particularly those receiving cardiotoxic treatments. Regular assessments of heart function (e.g., ejection fraction, cardiac biomarkers) can be tracked within the system, allowing for early detection of cardiovascular issues​​. 
  • GEMMS ONE enables virtual consultations and remote monitoring for cancer patients undergoing treatment. This is particularly valuable for high-risk patients, allowing cardio-oncologists to monitor cardiac function remotely and adjust treatments as needed without requiring frequent in-office visits​​.

4. Customized Clinical Decision Support

  • GEMMS ONE’s clinical decision support system provides real-time alerts when a patient is at increased risk of developing cardiotoxicity based on their treatment plan. This allows cardio-oncologists to proactively manage potential cardiac issues​​. 
  • The system incorporates evidence-based guidelines for managing heart disease in cancer patients, helping cardio-oncologists make informed decisions on interventions such as starting cardio-protective medications (e.g., beta-blockers, ACE inhibitors) to prevent heart damage during cancer therapy​​.  of shared care plans for ACHD patients, ensuring that all healthcare providers, including specialists in cardiology, surgery, and rehabilitation, are aligned on the patient’s management strategy. This improves the overall quality of care and reduces the likelihood of care gaps​​.

5. Imaging and Diagnostic Data Integration

  • GEMMS ONE integrates with imaging systems such as echocardiography and MRI, which are critical for monitoring heart function during and after cancer treatment. Imaging results are automatically stored within the patient’s chart, making it easy to track changes in heart function over time​​. 
  • GEMMS ONE allows cardio-oncologists to gather and analyze diagnostic data, including laboratory tests and imaging studies, in one place. This facilitates quick decision-making when adjustments in cancer treatment or cardiology care are required​. 

6. Patient Engagement and Communication

  • GEMMS ONE’s Patient Portal enables patients to stay informed about their cardiovascular health throughout their cancer treatment. Patients can access their test results, treatment plans, and communicate directly with their care teams (cardiologists and oncologists) via secure messaging​​. 
  • Cardio-oncologists can provide personalized educational resources through the Patient Portal, explaining the potential cardiac side effects of cancer treatments and offering guidance on how to minimize cardiovascular risks. 

7. Long-Term Follow-Up for Cancer Survivors

  • GEMMS ONE supports the development of long-term care plans for cancer survivors who may be at risk for developing cardiovascular disease as a result of their cancer treatments. This allows for ongoing monitoring and proactive management of heart health long after the cancer treatment has ended​​.
  • For cancer survivors who develop chronic heart conditions such as heart failure or hypertension due to their treatment, GEMMS ONE supports long-term management with built-in templates and tools to monitor and adjust treatment plans based on the patient’s evolving needs​​.

8. Customizable Templates and Reporting

  • GEMMS ONE allows cardio-oncologists to customize templates for documenting patient visits, procedures, and follow-ups. These templates can be tailored to the specific needs of cardio-oncology, including detailed documentation of cancer treatments, cardiac function tests, and patient symptoms​. 
  • The system offers robust reporting capabilities, enabling cardio-oncologists to generate detailed reports on patient outcomes, treatment efficacy, and cardiotoxicity monitoring. These reports are useful for internal audits, quality improvement, and compliance with regulatory requirements​. 

GEMMS ONE is
your complete EHR solution.

Schedule a Demo

Prebook Your Demo

Fill in your details here.